サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：生体適合性コーティングの世界市場の評価：タイプ別、グレード別、材料別、エンドユーザー別、地域別、機会、予測（2016年～2030年）
市場調査レポート
商品コード
1352091

生体適合性コーティングの世界市場の評価：タイプ別、グレード別、材料別、エンドユーザー別、地域別、機会、予測（2016年～2030年）

Biocompatible Coatings Market Assessment, By Type, By Grade, By Materials, By End-user, By Region, Opportunities and Forecast, 2016-2030F

出版日
ページ情報
英文 141 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
生体適合性コーティングの世界市場の評価：タイプ別、グレード別、材料別、エンドユーザー別、地域別、機会、予測（2016年～2030年）
出版日: 2023年09月28日
発行: Market Xcel - Markets and Data
ページ情報: 英文 141 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の生体適合性コーティングの市場規模は、2022年の154億米ドルから2030年に412億米ドルに達し、2023年～2030年の予測期間にCAGRで13.1%の成長が予測されています。生体適合性コーティングは、今後数年に大きな発展が見込まれる、医療機器部門で必要とされるコーティング技術の開発を重視しています。

血液適合性コーティングの成長

市場の上市済みの製品は、医療グレードに適用するには血液適合性が不十分です。血液適合性コーティングソリューションは、医療機器上での血液凝固を抑制する上で、医療部門を大きく牽引しています。

生体適合性コーティングと規制

急速な都市化とともに衛生製品への需要が高まり、消費者と家庭用製品における生体適合性コーティングの市場需要を促進しています。患者の安全性と製品の品質を確保するための厳しい規制や政府の条件は、生体適合性コーティングの導入を促しています。政府機関による規制は、医療機器メーカーに厳格なガイドラインを遵守させ、製品が承認および商品化される前に生体適合性に関する保証を提供することを強制しています。医療関連感染（HAI）は患者の症状を悪化させ、医療費の増加、精神的外傷の長期化、より深刻な転帰をもたらす可能性があります。EMAやFDAのような世界の政府機関は、治療の安全性を優先し、製造された医療機器が生体適合性基準を満たすことを保証する特定の規制を設けています。抗菌コーティングは病原体と闘い、感染症の伝播を抑制する上で非常に効果的です。

患者の安全に対する懸念の高まりから、政府機関は医療グレードのコンポーネントを開発するための厳格なガイドラインを取り入れることを余儀なくされています。このような機器に生体適合性基準を適用することで、企業は規制を満たすための革新的なソリューションを生み出すことができます。その結果、政府の規制は、より多くの医療関連企業が効果的なソリューションを生み出すために競争し、課された条件を達成するための技術革新を推進することで、巨大な市場の潜在性を生み出すことにもなります。

COVID-19の影響

COVID-19の大流行により、世界中でマスクや医療製品の不足が深刻化し、世界のサプライチェーンが大きく混乱しました。患者を積極的に治療するには、医療機器が不可欠であり、病院全体が深刻な懸念を抱きました。生体適合性コーティングの導入は、より多くの医療機器や装置の製造にこの技術を活用することで、医療用途に大きな革命をもたらしました。関連材料を使用した生体適合性コーティングの市場は爆発的に拡大し、さまざまな医療セグメンテーションで経験を積む絶好の機会を生み出しました。パンデミックの時期には、生体適合性医療機器への要求が高まり、医療産業は活況を呈しました。これにより、生体適合性コーティング産業は最大レベルの収益を上げるようになっています。

ロシア・ウクライナ戦争の影響

ロシアのウクライナ併合は世界の健康危機を引き起こし、莫大な死者、避難民、戦争で被害を受けた人々を支援する資金の不足につながっています。このような困難な状況にもかかわらず、近隣諸国や先進国からの医療機器や医薬品などの援助は、ウクライナにとって非常に重要なものとなっています。ニーズを満たすことへの需要は、生体適合性医療機器や食品包装製品の生産を増加させ、最終的に世界中で生体適合性コーティング剤市場につながりました。市場機会は、生体適合性コーティングを含むさまざまな医療部門で顕著に成長しています。

当レポートでは、世界の生体適合性コーティング市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 生体適合性コーティング市場に対するCOVID-19の影響

第4章 ロシア・ウクライナ戦争の影響

第5章 エグゼクティブサマリー

第6章 顧客の声

  • 市場の認知度と製品情報
  • ブランドの認知度とロイヤルティ
  • 購入決定において考慮される要素
  • 購入頻度
  • 購入媒体

第7章 生体適合性コーティング市場の見通し（2016年～2030年）

  • 市場規模と予測
    • 金額
    • 数量
  • タイプ別
    • 血液適合性コーティング
    • 抗菌コーティング
    • プレミックスコーティング（すぐに使用できる）
    • その他
  • グレード別
    • 医療グレード
    • 食品グレード
    • ラボグレード
  • 材料別
    • セラミックス
    • ポリマー
    • 金属・合金
    • その他
  • エンドユーザー別
    • 医療産業
    • 食品・飲料
    • その他
  • 地域別
    • 北米
    • 欧州
    • 南米
    • アジア太平洋
    • 中東・アフリカ
  • 市場シェア：企業別（2022年）

第8章 生体適合性コーティング市場の見通し：地域別（2016年～2030年）

  • 北米
    • 市場規模と予測
    • タイプ別
    • グレード別
    • 材料別
    • エンドユーザー別
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • ロシア
    • オランダ
    • スペイン
    • トルコ
    • ポーランド
  • 南米
    • ブラジル
    • アルゼンチン
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • オーストラリア
    • ベトナム
    • 韓国
    • インドネシア
    • フィリピン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第9章 サプライサイド分析

  • 生産能力：企業別
  • 生産：企業別
  • 営業効率：企業別
  • 主な工場の所在地（最大25）

第10章 市場マッピング（2022年）

  • モデル別
  • 用途別
  • エンドユーザー別
  • 地域別

第11章 マクロ環境と産業構造

  • 需給分析
  • 輸出入の分析 - 数量と金額
  • サプライ/バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第12章 市場力学

  • 成長促進要因
  • 成長抑制要因（課題、抑制要因）

第13章 主要企業情勢

  • マーケットリーダー上位5社の競合マトリクス
  • マーケットリーダー上位5社市場の収益分析（2022年）
  • 合併と買収/合弁事業（該当する場合）
  • SWOT分析（市場参入企業5社向け）
  • 特許分析（該当する場合）

第14章 価格分析

第15章 ケーススタディ

第16章 主要企業の見通し

  • Covalonoem Technologies
  • DSM Biomedical
  • SurModics, Inc.
  • Carmeda AB
  • Specialty Coating Systems Inc.
  • Elkem
  • Evonik
  • Medtronic
  • Hydromer Inc.
  • Innovative Surface Technologies

第17章 戦略的推奨事項

第18章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 2. Global Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 3. Global Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 4. Global Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 5. Global Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 6. Global Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 7. Global Biocompatible Coating Market Share, By Region, In USD Billion, 2016-2030F
  • Figure 8. North America Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 9. North America Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 10. North America Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 11. North America Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 12. North America Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 13. North America Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 14. North America Biocompatible Coating Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 15. United States Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 16. United States Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 17. United States Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 18. United States Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 19. United States Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 20. United States Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 21. Canada Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 22. Canada Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 23. Canada Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 24. Canada Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 25. Canada Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 26. Canada Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 27. Mexico Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 28. Mexico Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 29. Mexico Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 30. Mexico Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 31. Mexico Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 32. Mexico Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 33. Europe Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 34. Europe Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 35. Europe Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 36. Europe Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 37. Europe Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 38. Europe Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 39. Europe Biocompatible Coating Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 40. Germany Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 41. Germany Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 42. Germany Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 43. Germany Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 44. Germany Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 45. Germany Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 46. France Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 47. France Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 48. France Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 49. France Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 50. France Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 51. France Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 52. Italy Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 53. Italy Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 54. Italy Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 55. Italy Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 56. Italy Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 57. Italy Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 58. United Kingdom Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 59. United Kingdom Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 60. United Kingdom Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 61. United Kingdom Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 62. United Kingdom Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 63. United Kingdom Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 64. Russia Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 65. Russia Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 66. Russia Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 67. Russia Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 68. Russia Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 69. Russia Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 70. Netherlands Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 71. Netherlands Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 72. Netherlands Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 73. Netherlands Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 74. Netherlands Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 75. Netherlands Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 76. Spain Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 77. Spain Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 78. Spain Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 79. Spain Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 80. Spain Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 81. Spain Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 82. Turkey Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 83. Turkey Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 84. Turkey Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 85. Turkey Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 86. Turkey Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 87. Turkey Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 88. Poland Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 89. Poland Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 90. Poland Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 91. Poland Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 92. Poland Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 93. Poland Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 94. South America Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 95. South America Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 96. South America Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 97. South America Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 98. South America Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 99. South America Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 100. South America Biocompatible Coating Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 101. Brazil Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 102. Brazil Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 103. Brazil Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 104. Brazil Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 105. Brazil Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 106. Brazil Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 107. Argentina Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 108. Argentina Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 109. Argentina Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 110. Argentina Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 111. Argentina Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 112. Argentina Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 113. Asia-Pacific Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 114. Asia-Pacific Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 115. Asia-Pacific Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 116. Asia-Pacific Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 117. Asia-Pacific Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 118. Asia- Pacific Cream Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 119. Asia-Pacific Biocompatible Coating Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 120. India Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 121. India Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 122. India Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 123. India Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 124. India Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 125. India Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 126. China Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 127. China Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 128. China Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 129. China Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 130. China Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 131. China Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 132. Japan Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 133. Japan Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 134. Japan Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 135. Japan Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 136. Japan Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 137. Japan Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 138. Australia Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 139. Australia Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 140. Australia Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 141. Australia Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 142. Australia Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 143. Australia Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 144. Vietnam Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 145. Vietnam Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 146. Vietnam Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 147. Vietnam Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 148. Vietnam Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 149. Vietnam Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 150. South Korea Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 151. South Korea Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 152. South Korea Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 153. South Korea Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 154. South Korea Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 155. South Korea Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 156. Indonesia Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 157. Indonesia Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 158. Indonesia Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 159. Indonesia Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 160. Indonesia Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 161. Indonesia Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 162. Philippines Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 163. Philippines Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 164. Philippines Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 165. Philippines Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 166. Philippines Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 167. Philippines Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 168. Middle East & Africa Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 169. Middle East & Africa Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 170. Middle East & Africa Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 171. Middle East & Africa Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 172. Middle East & Africa Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 173. Middle East & Africa Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 174. Middle East & Africa Biocompatible Coating Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 175. Saudi Arabia Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 176. Saudi Arabia Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 177. Saudi Arabia Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 178. Saudi Arabia Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 179. Saudi Arabia Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 180. Saudi Arabia Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 181. UAE Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 182. UAE Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 183. UAE Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 184. UAE Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 185. UAE Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 186. UAE Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 187. South Africa Biocompatible Coating Market, By Value, In USD Billion, 2016-2030F
  • Figure 188. South Africa Biocompatible Coating Market, By Volume, In Tons, 2016-2030F
  • Figure 189. South Africa Biocompatible Coating Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 190. South Africa Biocompatible Coating Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 191. South Africa Biocompatible Coating Market Share, By Material, In USD Billion, 2016-2030F
  • Figure 192. South Africa Biocompatible Coating Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 193. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 194. By Grade Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 195. By Material Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 196. By End-User Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2022
目次
Product Code: MX10427

Global biocompatible coatings market size was valued at USD 15.4 billion in 2022, which is expected to reach USD 41.2 billion in 2030, with a CAGR of 13.1% for the forecast period between 2023 and 2030. Biocompatible coating emphasizes developing coating technologies, which are required in the medical devices sector which is expected to incur major development in the coming years. With the concern of patient safety biocompatible coatings become crucial in enhancing the functionality and biocompatibility of medical devices, implants, and prominent equipment.

Biocompatible coatings are used for imparting antimicrobial activities using development of cementless hydroxyapatite (HA)-coated titanium orthopedic prostheses. Hemocompatible coatings are significantly related to thrombogenic and thromboembolic complications where the coating is applied on medical-grade materials. Hemocompatible coatings comprises of active and passive types which have their specific characteristics. Ceramic oxide coatings for biomedical purposes are extensively used for damaged bone tissue and joint replacement. Aumina and zirconia are suitable ceramic materials used, because of their unique characteristics such as excellent wear resistance and biocompatibility. The progressive drivers for biocompatible coatings materials carry enormous potential for global market and create massive opportunities to expand in different segmentation.

Growth in Hemocompatible Coatings

Hemocompatible has high tolerance with blood, which is associated to thrombogenic and thromboembolic complications induced by biomaterial surfaces. Commercial products in the market products possess inadequate hemocompatibility for application in the medical grade. Hemocompatible coating solutions are tremendously driving the medical sector in inhibiting blood coagulation on the medical device. Health-driven companies are significantly producing such effective devices using biocompatible coatings, creating huge market opportunities as the technology requires prominent usage of materials.

Surmodics's proprietary PhotoLink UV curing technology can successfully develop coatings for all medical-grade materials using light-activated chemistry that generate bonds rapidly. Their exceptional coating solutions can easily integrate into existing manufacturing systems and enhance medical device functioning. Active (heparin) and passive (non-heparin) hemocompatible coatings inhibit thrombin generation and reduce protein adsorption. The significance of biocompatible coatings can be explored in different medical devices which will open global market opportunities by introducing more innovations for such coatings.

Biocompatible Coatings and Regulations

Rapid urbanization along with demand for hygienic products has raised concerns which is driving the market demand for biocompatible coatings in consumer and household products. Stringent regulations and government conditions on ensuring patient safety and product quality encourages to implement biocompatible coatings. Regulations by government entities have bounded medical device manufacturers to adhere stringent guidelines and provide assurance about biocompatibility before products can be approved and commercialized. Healthcare-associated infections (HAIs) can exacerbate the patient's conditions, increasing healthcare costs, prolonged mental trauma, and more severe outcomes. Global government agencies like European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA) have created specific regulations that prioritize safety in treatments and ensure manufactured medical devices should meet the biocompatibility standards. Antibacterial coatings are highly effective in combating pathogens and restricting the transmission of infections.

The rising concerns for patient safety is forcing government agencies to incorporate stringent guidelines for developing medical grade components. Applying biocompatibility standards on such devices encourages companies to generate innovative solutions to meet the regulations. Consequently, government regulations can also create huge market potential as more medical companies compete to generate effective solutions and drive innovation in achieving the imposed conditions.

Impact of COVID-19

The COVID-19 pandemic severely led to shortage of masks and healthcare products across the globe and global supply chain was prominently disrupted. The indispensable need for medical devices was serious concerns across the hospitals to provide active patient treatment. Incorporation of biocompatible coatings significantly revolutionized medical applications by utilizing the technology in building more medical devices and equipment. The market for biocompatible coating using relevant materials exploded and generated excellent opportunities to gain experience in various medical segmentation. The pandemic time was a boom for medical industries by increasing requirement of biocompatible medical devices which has created immense potential for building devices that biocompatible norms must regulate. This has taken the biocompatible coating industry to the utmost level of revenue generation.

Impact of Russia-Ukraine War

The annexation of Russia on Ukraine has sparked global health crises which led to enormous decease, displacement of people, and lack in sufficient funds to support people affected from the war. Despite the prevailing difficulties, aid from other neighboring and developed countries such as medical devices, useful medicines, etc. has significantly became crucial for Ukraine. The demand to fulfill the needs has increased the production of biocompatible medical devices and food packaged products which ultimately derived the biocompatible coatings market across the globe. The market opportunities have grown prominently in various health care sectors including biocompatible coatings.

Key Players Landscape and Outlook

The advancement in biocompatible coating technologies has prominently gained interest to incorporate in various medical applications such as device-based therapies, blood-contacted equipment, etc. Evonik has successfully commenced proprietary surface modification technology called Endexo, which is based on low molecular weight fluoro-oligomers which significantly assist in enhancing the biocompatibility of medical devices making direct contact with blood, tissue, and other body fluids. It possesses surface modifying characteristics that impart permanent and durable modification of surface properties without altering or impacting the device dimensions or its functionality. Surface modification using Endexo biocompatible coating technology can effectively reduce around 99% platelet adhesion and thrombus formation from blood contacting-devices such as vascular stents, catheters, etc. The importance of biocompatible coating technologies in medical applications can be recognized which has immense potential for global market to grow non-linearly.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on the Biocompatible coatings Market

4. Impact of Russia-Ukraine War

5. Executive Summary

6. Voice of Customer

  • 6.1. Market Awareness and Product Information
  • 6.2. Brand Awareness and Loyalty
  • 6.3. Factors Considered in Purchase Decision
    • 6.3.1. Brand Name
    • 6.3.2. Quality
    • 6.3.3. Quantity
    • 6.3.4. Price
    • 6.3.5. Product Specification
    • 6.3.6. Application Specification
    • 6.3.7. Shelf-life
    • 6.3.8. Availability of Product
  • 6.4. Frequency of Purchase
  • 6.5. Medium of Purchase

7. Biocompatible Coatings Market Outlook, 2016-2030F

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
    • 7.1.2. By Volume
  • 7.2. By Type
    • 7.2.1. Hemocompatible Coatings
      • 7.2.1.1. Active
      • 7.2.1.2. Passive
    • 7.2.2. Antibacterial Coatings
      • 7.2.2.1. Antibiotics-releasing
      • 7.2.2.2. Antibiotics-graft
      • 7.2.2.3. Silver-containing
      • 7.2.2.4. Others
    • 7.2.3. Pre-Mixed Coatings (ready-to-use)
    • 7.2.4. Others
  • 7.3. By Grade
    • 7.3.1. Medical Grade
    • 7.3.2. Food Grade
    • 7.3.3. Lab Grade
  • 7.4. By Materials
    • 7.4.1. Ceramics
    • 7.4.2. Polymers
    • 7.4.3. Metals & Alloys
    • 7.4.4. Others
  • 7.5. By End-user
    • 7.5.1. Healthcare Industry
      • 7.5.1.1. Medical Devices
      • 7.5.1.2. Pharmaceutical Drugs
    • 7.5.2. Food & Beverage
    • 7.5.3. Others
  • 7.6. By Region
    • 7.6.1. North America
    • 7.6.2. Europe
    • 7.6.3. South America
    • 7.6.4. Asia-Pacific
    • 7.6.5. Middle East and Africa
  • 7.7. By Company Market Share (%), 2022

8. Biocompatible coatings Market Outlook, By Region, 2016-2030F

  • 8.1. North America*
    • 8.1.1. Market Size & Forecast
      • 8.1.1.1. By Value
      • 8.1.1.2. By Volume
    • 8.1.2. By Type
      • 8.1.2.1. Hemocompatible Coatings
      • 8.1.2.1.1. Active
      • 8.1.2.1.2. Passive
      • 8.1.2.2. Antibacterial Coatings
      • 8.1.2.2.1. Antibiotics-releasing
      • 8.1.2.2.2. Antibiotics-graft
      • 8.1.2.2.3. Silver-containing
      • 8.1.2.2.4. Others
      • 8.1.2.3. Pre-Mixed Coatings (ready-to-use)
      • 8.1.2.4. Others
    • 8.1.3. By Grade
      • 8.1.3.1. Medical Grade
      • 8.1.3.2. Food Grade
      • 8.1.3.3. Lab Grade
    • 8.1.4. By Materials
      • 8.1.4.1. Ceramics
      • 8.1.4.2. Polymers
      • 8.1.4.3. Metals & Alloys
      • 8.1.4.4. Others
    • 8.1.5. By End-user
      • 8.1.5.1. Healthcare Industry
      • 8.1.5.1.1. Medical Devices
      • 8.1.5.1.2. Pharmaceutical Drugs
      • 8.1.5.2. Food & Beverage
      • 8.1.5.3. Others
    • 8.1.6. United States*
      • 8.1.6.1. Market Size & Forecast
      • 8.1.6.1.1. By Value
      • 8.1.6.1.2. By Volume
      • 8.1.6.2. By Type
      • 8.1.6.2.1. Hemocompatible Coatings
      • 8.1.6.2.1.1. Active
      • 8.1.6.2.1.2. Passive
      • 8.1.6.2.2. Antibacterial Coatings
      • 8.1.6.2.2.1. Antibiotics-releasing
      • 8.1.6.2.2.2. Antibiotics-graft
      • 8.1.6.2.2.3. Silver-containing
      • 8.1.6.2.2.4. Others
      • 8.1.6.2.3. Pre-Mixed Coatings (ready-to-use)
      • 8.1.6.2.4. Others
      • 8.1.6.3. By Grade
      • 8.1.6.3.1. Medical Grade
      • 8.1.6.3.2. Food Grade
      • 8.1.6.3.3. Lab Grade
      • 8.1.6.4. By Materials
      • 8.1.6.4.1. Ceramics
      • 8.1.6.4.2. Polymers
      • 8.1.6.4.3. Metals & Alloys
      • 8.1.6.4.4. Others
      • 8.1.6.5. By End-user
      • 8.1.6.5.1. Healthcare Industry
      • 8.1.6.5.1.1. Medical Devices
      • 8.1.6.5.1.2. Pharmaceutical Drugs
      • 8.1.6.5.2. Food & Beverage
      • 8.1.6.5.3. Others
    • 8.1.7. Canada
    • 8.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 8.2. Europe
    • 8.2.1. Germany
    • 8.2.2. France
    • 8.2.3. Italy
    • 8.2.4. United Kingdom
    • 8.2.5. Russia
    • 8.2.6. Netherlands
    • 8.2.7. Spain
    • 8.2.8. Turkey
    • 8.2.9. Poland
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
  • 8.4. Asia-Pacific
    • 8.4.1. India
    • 8.4.2. China
    • 8.4.3. Japan
    • 8.4.4. Australia
    • 8.4.5. Vietnam
    • 8.4.6. South Korea
    • 8.4.7. Indonesia
    • 8.4.8. Philippines
  • 8.5. Middle East & Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. South Africa

9. Supply Side Analysis

  • 9.1. Capacity, By Company
  • 9.2. Production, By Company
  • 9.3. Operating Efficiency, By Company
  • 9.4. Key Plant Locations (Up to 25)

10. Market Mapping, 2022

  • 10.1. By Model
  • 10.2. By Application
  • 10.3. By End-user
  • 10.4. By Region

11. Macro Environment and Industry Structure

  • 11.1. Supply Demand Analysis
  • 11.2. Import Export Analysis - Volume and Value
  • 11.3. Supply/Value Chain Analysis
  • 11.4. PESTEL Analysis
    • 11.4.1. Political Factors
    • 11.4.2. Economic System
    • 11.4.3. Social Implications
    • 11.4.4. Technological Advancements
    • 11.4.5. Environmental Impacts
    • 11.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 11.5. Porter's Five Forces Analysis
    • 11.5.1. Supplier Power
    • 11.5.2. Buyer Power
    • 11.5.3. Substitution Threat
    • 11.5.4. Threat from New Entrant
    • 11.5.5. Competitive Rivalry

12. Market Dynamics

  • 12.1. Growth Drivers
  • 12.2. Growth Inhibitors (Challenges, Restraints)

13. Key Players Landscape

  • 13.1. Competition Matrix of Top Five Market Leaders
  • 13.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
  • 13.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 13.4. SWOT Analysis (For Five Market Players)
  • 13.5. Patent Analysis (If Applicable)

14. Pricing Analysis

15. Case Studies

16. Key Players Outlook

  • 16.1. Covalonoem Technologies
    • 16.1.1. Company Details
    • 16.1.2. Key Management Personnel
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As reported)
    • 16.1.5. Key Market Focus & Geographical Presence
    • 16.1.6. Recent Developments
  • 16.2. DSM Biomedical
  • 16.3. SurModics, Inc.
  • 16.4. Carmeda AB
  • 16.5. Specialty Coating Systems Inc.
  • 16.6. Elkem
  • 16.7. Evonik
  • 16.8. Medtronic
  • 16.9. Hydromer Inc.
  • 16.10. Innovative Surface Technologies

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

17. Strategic Recommendations

18. About Us & Disclaimer